Illumina (ILMN) : The traders have covered their outstanding shorts in Illumina (ILMN) to the tune of -370,382 shares, a change of -5.7%. As on Jul 29, 2016, the outstanding shorts on the stock were 6,460,959 shares, however, by August 15, 2016, the shorts had reduced to 6,090,577 shares. The covering shows that the traders dont believe that a large downside exists in the stock from current levels. The open short positions equal 4.2% of the free float of the stock. It takes 6 days to cover the outstanding short positions. The stock has an average daily volume of 971,163 shares. The short interest information was released on Wednesday Aug 24th after the market close.
Illumina (NASDAQ:ILMN): The stock opened at $173.21 on Wednesday but the bulls could not build on the opening and the stock topped out at $173.95 for the day. The stock traded down to $167.79 during the day, due to lack of any buying support eventually closed down at $169.54 with a loss of -1.88% for the day. The stock had closed at $172.79 on the previous day. The total traded volume was 1,022,140 shares.
In a related news, The director, of Illumina Inc, Bradbury Daniel had unloaded 600 shares at $168.42 per share in a transaction on August 17, 2016. The total value of transaction was $101,052. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Illumina, Inc. is engaged in production development of sequencing-and array-based solutions for genetic analysis. The Company offers integrated systems, consumables and analysis tools for genetic analysis. It also manufactures sequencing and array platforms, reagent kits and scanning equipment. Its customers include genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories, pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Its sequencing instruments perform a range of nucleic-acid analyses across a range of sample sizes. Its products and services are used for basic analysis and research, including de novo sequencing, genetic variation analysis, epigenetics and targeted screening, among others. It also provides products and services for other life sciences applied markets, such as agrigenomics. It also offers Clarity Run Manager, Clarity LIMS Silver and Clarity LIMS Gold.